Page results
-
The Lysholm Department of Neuroradiology is a multidisciplinary team of healthcare professionals providing leading-edge neuroradiological services, performing around 60,000 examinations and procedures per year.
-
This page explains what you can expect during recovery from your CAR T-cell therapy.
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients.
-
The department provides a unique and highly specialised clinical neuropsychological diagnostic and therapeutic service for in- and outpatients.
-
On 13 January 2020, a consultation which asks for people’s views on the future of planned orthopaedic surgery for adults in north central London was launched.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
Information about the council of governors at University College London Hospitals NHS Foundation Trust
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
This is an easy read page for patients with deep vein thrombosis (DVT).
File results
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments